Almirall announces a restructuring plan in Spain
- Almirall SA has announced today a restructuring plan in Spain, which will affect a maximum of 121 people, with the aim of supporting the new growth drivers of the company.
Barcelona, 18th October 2016
The objective of this plan is to streamline operations and particularly to reallocate resources in order to provide the required support to the new growth drivers of the company as a result of its own R&D as well as from successful business development projects over the last 18 months. These include three clinical projects in phase 3 and one new chemical entity in phase 1, the preparation towards the launch in Europe of two new products to treat psoriasis, one of them being a biologic product, and to continue providing support to the new launches in the USA as well as the growth in aesthetics.
In parallel the company is engaged in an exercise to implement zero base budgeting across all its operations as a way to further free up resources to support those same objectives.
This necessary adjustment in the workforce will be carried out with the utmost respect to our employees, and therefore Almirall will propose an appropriate social plan to minimize its effects.
About Almirall
Almirall is a global company based in Barcelona dedicated to providing valuable medicines and medical devices through its R&D, agreements and alliances. Our work covers the whole of the drug value chain. A consolidated growth allows us to devote our talent and efforts towards specialty areas and particularly to further grow as a leading Dermatology player. We are a specialist company, enabling us to accomplish the purpose of providing our innovative products wherever they are needed.
Founded in 1943, Almirall is listed on the Spanish Stock Exchange (ticker: ALM) and it has become a source of value creation for society due to its vision, and the commitment of its long-standing major shareholders. In 2015, Almirall revenues totalled 769 million euros and, with 1,800 employees, it has become a trusted presence across Europe, as well as in the US.
For more information, please visit www.almirall.com.
Media contact: Investors Relations contact:
Cohn & Wolfe Almirall
Adriana Ibargüen Pablo Divasson del Fraile
adriana.ibarguen@cohnwolfe.com Tel.: + (34) 93 291 30 87
Tel.: (+34) 91 531 57 23 / 616 08 23 06
Press release